Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer TherapyFabian B. Kraft, Finn K. Hansen|Pharmaceuticals|2023Cited by 28
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase DegradersFelix Feller, Finn K. Hansen|Journal of Medicinal Chemistry|2025Cited by 13
Development of the first geldanamycin-based HSP90 degradersSilas Wurnig, Finn K. Hansen|Frontiers in Chemistry|2023Cited by 11
Solid-phase synthesis of cereblon-recruiting selective histone deacetylase 6 degraders (HDAC6 PROTACs) with anti-leukemic activityLaura Sinatra, Finn K. Hansen|ChemRxiv|2022Cited by 5
DCAF16‐Based Covalent Molecular Glues for Targeted Protein Degradation of Histone DeacetylasesTao Sun, Finn K. Hansen|Archiv der Pharmazie|2025Cited by 2